Isak Im
Impact in
-
- Neuroinflammation and Neurodegeneration Mechanisms
Papers in
-
- Signaling Pathways in Disease 2
- Receptor Mechanisms and Signaling 2
-
- Synthesis and Biological Evaluation 3
- Co-authors
- Yong‐Chul Kim (11 shared papers)Jae‐Il Kim (2 shared papers)Sangjun Park (1 shared paper)Eunju Lee (1 shared paper)Je‐Wook Yu (1 shared paper)Jiho Jang (1 shared paper)Wonsuk Yang (1 shared paper)Inhwa Hwang (1 shared paper)
- Journals
- European Journal of Medicinal Chemistry (2 papers)ChemBioChem (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Journal of the American Chemical Society (1 paper)Molecules and Cells (1 paper)
- Partner nations
- South KoreaUnited StatesJapan
In The Last Decade
Isak Im
15 papers receiving 525 citations
Peers
Comparison fields: 5 of 76
- Neurology 59
- Geriatrics and Gerontology 23
- Organic Chemistry 147
- Physiology 20
- Molecular Biology 295
Countries citing papers authored by Isak Im
This map shows the geographic impact of Isak Im's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isak Im with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isak Im more than expected).
Fields of papers citing papers by Isak Im
This network shows the impact of papers produced by Isak Im. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isak Im. The network helps show where Isak Im may publish in the future.
Co-authors
The 25 scholars most cited alongside Isak Im, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 125 | |
| 2 | 2013 | 102 | |
| 3 | 2010 | 86 | |
| 4 | 2014 | 32 | |
| 5 | 2005 | 30 | |
| 6 | 2010 | 29 | |
| 7 | 2009 | 29 | |
| 8 | 2004 | 23 | |
| 9 | 2009 | 20 | |
| 10 | 2007 | 18 | |
| 11 | 2004 | 13 | |
| 12 | 2011 | 12 | |
| 13 | 2009 | 9 | |
| 14 | 2012 | 5 | |
| 15 | 2010 | 1 | |
| 16 | 2011 | 0 |
About Isak Im
Isak Im is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Cardiology and Cardiovascular Medicine and Computational Theory and Mathematics, having authored 16 papers that have together received 534 indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (3 papers), Synthesis and Biological Evaluation (3 papers), Signaling Pathways in Disease (2 papers), Alzheimer's disease research and treatments (2 papers), Neuropeptides and Animal Physiology (2 papers), Sirtuins and Resveratrol in Medicine (2 papers), PARP inhibition in cancer therapy (2 papers) and Receptor Mechanisms and Signaling (2 papers). The work is most often cited by research in Neurology (59 citations), Geriatrics and Gerontology (23 citations), Organic Chemistry (147 citations), Physiology (20 citations) and Molecular Biology (295 citations). Isak Im has collaborated with scholars based in South Korea, United States and Japan. Frequent co-authors include Yong‐Chul Kim, Jae‐Il Kim, Sangjun Park, Eunju Lee, Je‐Wook Yu, Jiho Jang, Wonsuk Yang, Inhwa Hwang, Hyun‐Ju Cho and Hoon‐Chul Kang. Their work appears in journals such as European Journal of Medicinal Chemistry, ChemBioChem, Bioorganic & Medicinal Chemistry Letters, Journal of the American Chemical Society and Molecules and Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.